<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03085576</url>
  </required_header>
  <id_info>
    <org_study_id>DAC-001-NATUREAF</org_study_id>
    <nct_id>NCT03085576</nct_id>
  </id_info>
  <brief_title>NATional TUnisian REgistry of Atrial Fibrillation</brief_title>
  <acronym>NATURE-AF</acronym>
  <official_title>National Tunisian Registry of Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dacima Consulting</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Société Tunisienne de Cardiologie &amp; de Chirurgie Cardio-Vasculaire</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dacima Consulting</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A non-interventional, national longitudinal study of atrial fibrillation performed with 91
      cardiologists.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The NATURE-AF study is carried out in Tunisia at cardiology consultations in hospitals and in
      the liberal sector. A total of 91 cardiologists participate in the selection of patients as
      investigators. The study is a longitudinal non-interventional registry of atrial
      fibrillation. The data collected are managed by the DACIMA Clinical Suite® platform, which
      complies with international standards: FDA 21 CFR part 11 (Food and Drug Administration 21
      Code of Federal Regulations part 11), HIPPA (Health Insurance Portability and Accountability
      Act), ICH (International Conference on Harmonisation), MedDRA (Medical Dictionary for
      Regulatory Activities). The DACIMA Clinical Suite® platform allows to track the data entered,
      check for inconsistencies and missing data, and schedule monitoring visits. A Steering
      Committee is set up to monitor patient inclusions, verify data sources, perform audit trails
      and prepare the statistical analysis plan for the study.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">May 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Incidence of stroke or transient ischemic attack, thromboembolic events and cardiovascular death</measure>
    <time_frame>Every 3 months up to 1 year</time_frame>
    <description>Number of patients with ischemic stroke and/or transient ischemic attack, and/or arterial embolization during the follow-up period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Haemorrhagic accidents</measure>
    <time_frame>Every 3 months up to 1 year</time_frame>
    <description>All bleeding events (digestive, cerebral, other locations)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of INR (International Normalized Ratio)</measure>
    <time_frame>Every month for 1 year</time_frame>
    <description>INR measurement of venous blood sampling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TTR (percent Time in Therapeutic INR Range)</measure>
    <time_frame>1 year</time_frame>
    <description>The mean TTR obtained in patients who received anticoagulant therapy</description>
  </secondary_outcome>
  <enrollment type="Actual">910</enrollment>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with atrial fibrillation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least one episode of atrial fibrillation, documented on a 12-lead ECG and / or a
             rhythmic holter (duration of the episode: 30 seconds or more)

          -  Recent atrial fibrillation diagnosed for less than a year

          -  Regular monitoring every 3 months is ensured

          -  Informed, read and signed consent

        Exclusion Criteria:

          -  Estimated life expectancy at less than 12 months

          -  Transient atrial fibrillation due to reversible cause (eg acute myocardial infarction,
             following cardiac surgery, acute alcohol intoxication, hyperthyroidism, pulmonary
             embolism or other acute pulmonary disease, pericarditis, myocarditis,
             hydro-electrolyte disorder, metabolic disorder)

          -  Cardiac surgery ≤ 3 months

          -  Atrial flutter isolated without atrial fibrillation

          -  Mental disorders

          -  Ongoing anticoagulation for reasons other than atrial fibrillation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faouzi Addad, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Société Tunisienne de Cardiologie et de Chirurgie Cardiovasculaire</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>STCCCV - Société Tunisienne de Cardiologie et de Chirurgie Cardio-Vasculaire</name>
      <address>
        <city>Tunis</city>
        <zip>1053</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2017</study_first_submitted>
  <study_first_submitted_qc>March 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2017</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Anticoagulation</keyword>
  <keyword>Stroke</keyword>
  <keyword>Vitamin K antagonist</keyword>
  <keyword>Cardioversion</keyword>
  <keyword>INR (International Normalized Ratio)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

